Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA)
Clinical Medicine Reviews in Therapeutics · 2011
DOI: 10.4137/cmrt.s1637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Medicine Reviews in Therapeutics, 2011. Verfasst von Christopher Duplessis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Division, Naval Medical Center San Diego, San Diego, CA United States. Die Arbeit wurde bisher 32-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Infectious Disease Division, Naval Medical Center San Diego, San Diego, CA United States.
Förderung
- NIAID NIH HHS
Zitieren
APA
Duplessis, C., & Crum-Cianflone, N. F. (2011). Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA). Clinical Medicine Reviews in Therapeutics. https://doi.org/10.4137/cmrt.s1637
Vancouver
Duplessis C, Crum-Cianflone NF. Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA). Clinical Medicine Reviews in Therapeutics. 2011. doi:10.4137/cmrt.s1637
BibTeX
@article{Duplessis2011,
author = {Duplessis, Christopher and Crum-Cianflone, Nancy F},
title = {Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA)},
journal = {Clinical Medicine Reviews in Therapeutics},
year = {2011},
doi = {10.4137/cmrt.s1637}
}
EUVIMED